atezolizumab,cabozantinib
roche,exelixis
['cosmic-021', 'urothelial', 'atezo', 'cabozantinib']
asco 2022 video: sumanta pal outlines results from three cohorts of the cosmic-021 trial pointing to the potential of combining cabozantinib with atezolizumab in treatment-na ve and pretreated advanced urothelial cancer.
Springer Healthcare IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.